SING GEORGE L
SEC CIK 1225471 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals | Dir | 31.0K | — | $25.62M | 30 | 2021-08-06 | 2026-01-02 |
Most active insiders at REGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | POON CHRISTINE A | Dir | — | $4.25M |
| 2 | McCourt Marion | EVP Commercial | — | $2.00M |
| 3 | Zoghbi Huda Y | Dir | — | $1.92M |
| 4 | Pitofsky Jason | VP Ctrl | — | $1.87M |
| 5 | Bassler Bonnie L | Dir | — | $1.77M |
| 6 | Guarini Kathryn | Dir | — | $660.0K |
| 7 | RYAN ARTHUR F | Dir | — | $434.7K |
| 8 | MURPHY ANDREW J | EVP Research | — | — |
| 9 | Fenimore Christopher R. | EVP Fin CFO | — | — |
| 10 | Schenkein David P | Dir | — | — |
| 16 | SING GEORGE L | Dir | — | — |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | A - Grant | $0.00 | +155 | 31.0K | +0.5% | $0 |
| D | 2025-12-31 | 2025-12-30 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | M - OptEx | $520.01 | +9,212 | 37.0K | +33% | +$4.79M |
| D | 2025-12-31 | 2025-12-30 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | F - Tax | $774.03 | -6,188 | 30.9K | -17% | -$4.79M |
| D | 2025-01-03 | 2024-12-31 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | F - Tax | $708.19 | -1,948 | 27.7K | -7% | -$1.38M |
| D | 2025-01-03 | 2024-12-31 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | M - OptEx | $413.33 | +3,338 | 29.6K | +13% | +$1.38M |
| D | 2025-01-03 | 2025-01-02 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | A - Grant | $0.00 | +166 | 27.8K | +0.6% | $0 |
| 2024-09-05 | 2024-09-04 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | G - Gift | $0.00 | -1,200 | 26.3K | -4% | $0 | |
| D | 2024-05-06 | 2024-05-03 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | F - Tax | $942.53 | -877 | 27.5K | -3% | -$826.6K |
| D | 2024-05-06 | 2024-05-03 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | M - OptEx | $413.33 | +2,000 | 28.3K | +8% | +$826.7K |
| DM | 2024-02-28 | 2024-02-26 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale+OE | $992.50 | -1,000 | 26.3K | -4% | -$992.5K |
| DM | 2024-02-28 | 2024-02-26 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | M - OptEx | $413.33 | +1,000 | 26.8K | +4% | +$413.3K |
| DM | 2024-02-26 | 2024-02-22+ | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale+OE | $967.86 | -3,500 | 26.3K | -12% | -$3.39M |
| DM | 2024-02-26 | 2024-02-22+ | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | M - OptEx | $413.33 | +3,500 | 26.8K | +15% | +$1.45M |
| DM | 2024-02-12 | 2024-02-08+ | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale+OE | $950.00 | -1,000 | 26.3K | -4% | -$950.0K |
| DM | 2024-02-12 | 2024-02-08+ | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | M - OptEx | $413.33 | +1,000 | 26.8K | +4% | +$413.3K |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | A - Grant | $0.00 | +135 | 26.3K | +0.5% | $0 |
| D | 2023-01-05 | 2023-01-03 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | A - Grant | $0.00 | +165 | 26.2K | +0.6% | $0 |
| M | 2022-03-01 | 2022-02-25+ | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale | $618.25 | -4,000 | 28.0K | -12% | -$2.47M |
| D | 2022-01-05 | 2022-01-03 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | A - Grant | $0.00 | +191 | 30.0K | +0.6% | $0 |
| M | 2021-11-23 | 2021-11-19+ | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale | $656.67 | -3,000 | 31.9K | -9% | -$1.97M |
| M | 2021-11-18 | 2021-11-16+ | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale | $653.76 | -10.0K | 32.9K | -23% | -$6.54M |
| I | 2021-11-18 | 2021-11-16 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale | $650.00 | -750 | 1,000 | -43% | -$487.5K |
| MI | 2021-08-30 | 2021-08-26+ | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale | $671.29 | -700 | 1,000 | -41% | -$469.9K |
| M | 2021-08-30 | 2021-08-30 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale | $672.50 | -1,000 | 42.9K | -2% | -$672.5K |
| I | 2021-08-17 | 2021-08-16 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale | $627.50 | -1,000 | 2,050 | -33% | -$627.5K |
| 2021-08-17 | 2021-08-16 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale | $630.00 | -705 | 43.9K | -2% | -$444.1K | |
| M | 2021-08-13 | 2021-08-11+ | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale | $617.71 | -3,500 | 44.6K | -7% | -$2.16M |
| I | 2021-08-13 | 2021-08-11 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale | $620.00 | -300 | 3,050 | -9% | -$186.0K |
| I | 2021-08-10 | 2021-08-06 | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale | $612.42 | -350 | 3,350 | -9% | -$214.3K |
| M | 2021-08-10 | 2021-08-06+ | REGN | Regeneron Pharmaceuticals | SING GEORGE L | Dir | S - Sale | $612.35 | -6,600 | 50.7K | -12% | -$4.04M |
Purchase Sale Sale after option exercise All abbreviations